Levocarnitine Uni-Pharma

Levocarnitine, the active ingredient in Levocarnitine Uni-Pharma, is an L‑carnitine nutritional supplement presented as an oral tablet for oral use. It is employed to treat primary and secondary carnitine deficiency and to support metabolic disorders by facilitating fatty‑acid transport into mitochondria, thereby aiding energy production.

GNH USA supplies Levocarnitine Uni-Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics, ensuring product integrity from manufacturing sites in the European Union to end‑users across global markets.

Levocarnitine is used to address disorders of carnitine metabolism and related metabolic conditions.

- Primary carnitine deficiency: restores intracellular carnitine levels and improves fatty‑acid oxidation. - Secondary carnitine deficiency: compensates for loss of carnitine due to renal disease, dialysis or certain medications. - Support of metabolic disorders: aids energy production in patients with fatty‑acid oxidation defects or mitochondrial dysfunction.

Levocarnitine is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset. - Vomiting: occasional emesis. - Diarrhea: loose stools. - Abdominal discomfort: cramping or pain. - Headache: transient head pain. - Fish‑like body odor: odor of sweat or urine.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or urticaria. - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Severe hypotension: sudden drop in blood pressure. - Elevated liver enzymes: signs of hepatic stress. - Metabolic acidosis: abnormal blood pH. - Muscle weakness: unexplained loss of strength.

Before initiating therapy, consider the following precautions.

- Renal impairment: monitor kidney function and adjust therapy as needed. - Pregnancy and lactation: consult a healthcare professional before use. - Concomitant medications: review for potential interactions. - Long‑term therapy: periodically assess plasma carnitine concentrations. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levocarnitine may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Valproic acid: may deplete carnitine stores, reducing efficacy. - Cisplatin: increased risk of nephrotoxicity when combined. - Phenobarbital: accelerates carnitine metabolism, lowering plasma levels.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR, monitor coagulation. - Insulin: carnitine may affect glucose utilization, adjust dose as needed. - Thyroid hormones: may modify metabolic response, observe thyroid function.